Glenview Capital Management’s Medtronic MDT Stock Holding History

Glenview Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-179,928	Closed	-$14.1M	–	49
2023 Q3	$14.1M	Buy	+179,928	New	+$15.1M	0.32%	39
2021 Q3	–	Sell	-267,912	Closed	-$33.3M	–	66
2021 Q2	$33.3M	Buy	267,912 +152,796	+133%	+$19.2M	0.55%	44
2021 Q1	$13.6M	Buy	115,116 +1,234	+1%	+$145K	0.23%	53
2020 Q4	$13.3M	Hold	113,882	–	–	0.31%	43
2020 Q3	$11.8M	Buy	+113,882	New	+$11.4M	0.37%	35
2020 Q2	–	Sell	-39,671	Closed	-$3.58M	–	52
2020 Q1	$3.58M	Buy	+39,671	New	+$4.22M	0.1%	42

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Glenview Capital Management's MDT Position: Q4 2023 in Review

Glenview Capital Management sold out of Medtronic (MDT) in Q4 2023, closing a stake of 179,928 shares — an estimated $14.1M sold.

Glenview Capital Management first reported a position in MDT in Q1 2020 and held it in 6 quarters. The position peaked at $33.3M in Q2 2021. 2,077 funds tracked by Wall St. Rank hold MDT as of Q4 2023.

Glenview Capital Management reported no remaining Medtronic position as of Q4 2023 after selling out during the quarter.
Glenview Capital Management sold 179,928 Medtronic shares in Q4 2023, an estimated $14.1M.
Glenview Capital Management first reported a position in Medtronic in Q1 2020 and held it in 6 quarters.
Glenview Capital Management's Medtronic position peaked at $33.3M in Q2 2021.
2,077 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.

Based on Glenview Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.